Skip to main content

Silence Therapeutics plc

SLN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001479615

No open-market purchases or sales by Silence Therapeutics plc insiders were filed in the last 90 days; 72 institutions reported holding it in 13F filings for Q2 2026, worth $236.2M in total; no superinvestor holds it.

Other share classesSLNCF

Q2 2025 vs. Q1 2025

How the institutions holding Silence Therapeutics plc changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of SLN: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders5955−4
Shares21.9M19.8M−2.16M (−9.8%)
Value$60.6M$108.0M+$47.4M (+78.2%)

New holders (9)

Institutions that held Silence Therapeutics plc at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to SLN in Q2 2025
InstitutionSharesValue% of portfolio
Ikarian Capital, LLC873,568$1.40M0.46%
Jane Street Group, LLC37,813$219.3K0.00%
Susquehanna International Group, LLP27,797$161.2K0.00%
Wexford Capital LP27,149$157.5K0.04%
Massar Capital Management, LP19,863$115.2K0.09%
Beacon Pointe Advisors, LLC11,615$67.4K0.00%
Cambridge Investment Research Advisors, Inc.10,194$59.0K0.00%
Principal Securities, Inc.17$990.00%
EverSource Wealth Advisors, LLC10$580.00%

Sold out (13)

Institutions that held Silence Therapeutics plc at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of SLN in Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Parkman Healthcare Partners LLC401,746$1.13M
Schonfeld Strategic Advisors LLC149,996$423.0K
Walleye Capital LLC136,150$383.9K
UBS Oconnor LLC62,639$176.6K
Citadel Advisors LLC62,441$176.1K
Shay Capital LLC47,728$134.6K
Jump Financial, LLC26,351$74.3K
Goldman Sachs Group Inc24,375$68.7K
Qube Research & Technologies Ltd18,913$53.3K
Point72 Asset Management, L.P.16,032$45.2K
Acadian Asset Management LLC12,153$34.0K
Cubist Systematic Strategies, LLC7,364$20.8K
FNY Investment Advisers, LLC7,000$19.0K